Notice Concerning Changes in Directors
Filed with TSE · · 1 page · English
Summary by 6ix AI
COSMOS Pharmaceutical Corporation has issued a notice regarding changes in its Board of Directors. The notice includes the nomination of new director candidates and the retirement of an existing director. Details about the career summary of the newly appointed director are also provided. The formal determination of job titles for the new directors will occur after the upcoming Annual General Meeting of Shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
COSMOS Pharmaceutical Corporation on 6ix
Earlier from COSMOS Pharmaceutical
- Consolidated Financial Results for the Fiscal Year Ended May 31, 2026[Japanese GAAP]
- COSMOS Pharmaceutical: Consolidated Financial Results for the Fiscal Year Ended May 31, 2022
Later from COSMOS Pharmaceutical
- View and Policy on Reduction of Investment Unit
- Consolidated Financial Results for the Three Months Ended August 31, 2026(Under Japanese GAAP)
Follow COSMOS Pharmaceutical into a list and get an email when it puts out news.
Follow COSMOS Pharmaceutical